The right expert matched to your program within 48 hours. Clinical, regulatory, evidence, commercial strategy, and talent — across 20 countries.
Early-stage biotech spinning up toward IND. You need people who have done this before — medical oversight, tox strategy, and CMC expertise that only comes from shipping. Hiring full-time would mean paying for roles you'll unwind in 18 months.
FIH dosing, dose escalation, early efficacy. One biostatistician gap can derail a readout by a month. You need someone who can land inside the protocol, not take six weeks to onboard.
Global trials. Multi-site operations. Regulatory scrutiny ramping. This is where fractional becomes strategic: depth on demand, specialists who've survived this phase before, accountability without the 18-month hiring cycle.
The submission window is the most expensive two months of the program. Regulatory strategists who've been through NDAs aren't available on LinkedIn — they're booked out. Peritia's network has them on deck.
Launch planning, market access, HEOR dossiers, medical affairs infrastructure — the commercial function that builds the value story. Peritia brings launch veterans with specific therapeutic area and geography expertise.
The match is free. The 48-hour promise is real. The first conversation is with a human who's been through this before.